"We're viewing it as exactly what has been communicated to us," a contact at the Greater Austin Chamber tells GlobeSt.com. "It is a delay. It is not bad news in that they have not selected another site and we're hoping it will resume, of course."
The drug company has scouted Austin sites under a shroud of secrecy and its identity has remained unknown. The Austin chamber refers to its effort to land the manufacturing facility as Project Atlantis.
The drug-maker had been looking for undeveloped land in the Austin area and had considered one site near Austin-Bergstrom International Airport. "We're a little disappointed to have it slowed down," the contact says. "But it certainly isn't the end of that one and we have others as well."
She says that four other projects that fall under the bioscience heading are in the works in Austin. The city's economic developers have set bioscience as one of the industries on which they are focusing efforts.
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more inforrmation visit Asset & Logo Licensing.
